Form 4 for ATNM Actinium Pharmaceuticals, Inc.
Accepted 2026-09-04 17:00:26 ET · period of report 2026-09-02 · accession 0001213900-26-097741 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-04 17:00 | 2026-09-02 | ATNM | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +1.78M | 1.97M | +965% | $0 |
| D | 2026-09-04 17:00 | 2026-09-02 | ATNM | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +1.13M | 1.13M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-02 | A | A | 753,600 | $0.00 | 938,081 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs"). These RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant. |
| 2 | Common | Common Stock | 2026-09-02 | A | A | 1,027,274 | $0.00 | 1,965,355 | D | — | — | (F2) Represents a grant of RSUs. These RSUs vest fully on the third anniversary of the date of grant. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-09-02 | A | A | 1,130,400 | $0.00 | 1,130,400 | D | $1.00 · — to 2036-09-02 | 1,130,400 Common Stock | (F3) The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant. |